S1802- Phase III Randomized Trial Of Standard Systemic Therapy (Sst) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery Or Radiation) Of The Primary Tumor In Metastatic Prostate Cancer
Posted Date: Oct 1, 2019
- Investigator: Robert Franklin
- Specialties: Cancer, Oncology, Prostate Cancer
- Type of Study: Drug
The goal of this study is to compare overall survival in metastatic prostate cancer patients who are randomized to standard systemic therapy (SST) plus definitive treatment of the primary tumor versus standard systemic therapy alone
Criteria:
To Be Eligible: Must Be Diagnosed With Prostate Cancer, >18 Years Of Age, No Other Prior Malignancy
Keywords:
Prostate Cancer, Oncology, Metastatic
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com